查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2011025

乳房攝影影像市場：按產品、技術、設備類型、類別、影像方法、應用和最終用戶分類－2026-2032年全球市場預測

Breast Imaging Market by Product, Technology, Equipment Type, Category, Imaging Modality, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，乳房攝影影像市場價值將達到 58.3 億美元，到 2026 年將成長至 63.1 億美元，到 2032 年將達到 103.5 億美元，複合年成長率為 8.52%。

主要市場統計數據
基準年 2025 58.3億美元
預計年份：2026年 63.1億美元
預測年份 2032 103.5億美元
複合年成長率 (%) 8.52%

從權威的角度看待乳房攝影。

在乳房攝影影像領域，技術的快速成熟、臨床優先事項的整合以及政策監管的加強，共同作用，重新定義了醫療服務提供者、保險公司和供應商開展篩檢和診斷的方式。影像硬體和軟體的最新進展，例如多維成像技術的改進和先進放射學工作流程的整合，正在重塑從篩檢到術前立體定向的臨床路徑。同時，醫療系統也在努力平衡財政限制與提高診斷準確性、降低複檢率以及擴大服務不足人群的就醫途徑等需求。

影像技術創新、軟體整合以及分散式醫療模式的融合正在重塑乳房攝影影像的診斷路徑和營運重點。

乳房攝影領域正經歷一場變革，這得益於影像技術的進步、軟體驅動的工作流程以及醫療服務模式的轉變，這些因素共同提升了診斷的準確性和操作的柔軟性。3D和高維度成像技術提高了病灶定性和手術計劃的準確性，而造影增強和混合成像方法則提高了複雜臨床場景下的敏感性。同時，從針對斷層合成和磁振造影最佳化的影像軟體，到能夠簡化工作流程並支援決策的放射學軟體，各種軟體創新都是硬體投資的重要補充。

關稅政策的變化如何重塑供應鏈、籌資策略和供應商關係，從而優先考慮韌性和總擁有成本 (TCO)。

美國近期推出的關稅政策對整個乳房攝影系統的供應鏈產生了累積影響，波及採購計畫、籌資策略以及與供應商的談判。依賴全球製造地的設備製造商正在重組其供應鏈，以應對不斷上漲的原料成本和關稅，這導致零件來源的重新分配、產品配置的重新設計，在某些情況下甚至需要搬遷生產基地，所有這些都是為了保持競爭力。

綜合細分分析揭示了產品、技術、設備、模式、應用和最終用戶趨勢如何交織，形成策略機會。

市場區隔洞察顯示，市場動態錯綜複雜，產品、技術、儀器類型、類別、成像方式、應用和最終用戶等各個面向均受到不同因素的影響。從產品角度來看，系統和軟體發揮互補作用。系統包括切片檢查引導設備、乳房磁振造影設備、超音波、乳房X乳房X光攝影攝影設備以及斷層合成設備；而軟體則包括針對特定成像方式客製化的成像平台以及能夠提升工作流程效率和診斷一致性的放射學解決方案。這種交互作用表明，對先進系統的投資通常需要同時在軟體方面投入，才能最大限度地發揮其臨床價值。

美洲、歐洲、中東和非洲以及亞太地區的部署差異決定了各個地區的部署和擴張策略。

區域趨勢正在影響三大主要區域—美洲、歐洲、中東和非洲以及亞太地區的投資重點、技術應用和營運策略。在美洲，受醫療機構整合、最佳化篩檢計畫以及私營部門積極參與推動，投資呈上升趨勢，這些因素加速了斷層合成技術和先進軟體平台的應用。同時，監管政策的更新和報銷方案的調整促使醫療機構升級影像設備、降低複檢率並實施能夠提高診斷信心的工具。

供應商差異化、夥伴關係和卓越服務如何創造競爭優勢並影響不同臨床環境中的應用。

乳房攝影成像領域的競爭格局由眾多參與者構成，包括傳統設備製造商、創新軟體供應商以及專注於特定成像方式解決方案的新興專業公司。老牌大型企業憑藉其規模優勢、服務網路以及涵蓋乳房X光攝影、超音波、磁振造影和斷層合成系統的廣泛產品系列，在醫院和大規模診斷中心保持著穩固的地位。同時，軟體公司則透過工作流程自動化、人工智慧驅動的檢測和分流功能以及支援遠端影像判讀和多學科協作的雲端架構來脫穎而出。

採取以行動為導向、優先排序和策略性措施，協調採購、技術整合和人才準備，以加速臨床影響和營運韌性。

產業領導者若想掌握市場發展機遇，應優先考慮一系列切實可行的策略，使技術投資與臨床工作流程和業務目標一致。首先，投資於互通性整合，從而支援多學科診療路徑，並加速人工智慧驅動的改進。優先採用開放標準和擴充性架構，有助於機構實施面向未來的解決方案，並減少影像設備和工作流程工具升級過程中的阻力。

一個透明的、混合方法的研究框架，結合了直接的臨床見解、監管審查和供應鏈分析，從而產生與決策直接相關的見解。

本分析基於嚴謹的混合方法研究途徑，透過檢驗定性和定量信息，確保提供可靠且具有決策意義的見解。主要研究包括對臨床負責人、放射科主任、採購專家和供應商高管進行結構化訪談和深入討論，以收集關於技術應用促進因素、部署挑戰和服務期望的第一手觀點。次要研究則全面檢視了同儕審查的臨床研究、監管指南和公開的技術規範，以檢驗關鍵成像模式的效能特徵和軟體功能。

透過強調技術、人才和採購方面的適應性整合，我們透過明確的、全面的分析，確保乳房攝影的臨床卓越性和營運韌性。

總之，乳房攝影的未來將取決於成像方式創新、軟體主導的工作流程最佳化以及在擴大服務範圍的同時保持診斷品質的策略部署模式之間的相互作用。醫療機構若能協調系統和影像軟體的投資、採用靈活的採購方式並重視人力資源開發，將更有利於把技術進步轉化為病患療效的提升。政策變化（包括價格趨勢）的累積影響凸顯了供應鏈彈性和供應商夥伴關係關係的重要性，而這種合作關係能夠應對成本波動，同時確保服務的連續性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：乳房攝影影像市場：依產品分類

  • 軟體
    • 醫學影像軟體
    • 放射診斷軟體
  • 系統
    • 切片檢查引導系統
    • 乳房磁振造影系統
    • 乳房超音波診斷系統
    • 乳房X光攝影系統
    • 斷層合成系統

第9章：乳房攝影影像市場：依技術分類

  • 2D成像
  • 3D成像
  • 4D成像

第10章：乳房攝影影像市場：依設備分類

  • 整合系統
  • 移動單元
  • 獨立設備

第11章：乳房攝影影像市場：依類別分類

  • 模擬醫學影像
  • 數位診斷影像

第12章乳房攝影影像市場：依影像方法分類

  • 乳房斷層合成
  • 造影乳房X光攝影
  • 數位乳房X光攝影
  • 磁振造影
  • 分子乳房影像
  • 超音波影像

第13章：乳房攝影影像市場：依應用領域分類

  • 乳房切片
  • 診斷性乳房攝影
  • 術前定位
  • 乳房X光檢查篩檢

第14章乳房攝影影像市場：依最終用戶分類

  • 門診手術中心
  • 癌症研究中心
  • 診斷影像中心
  • 醫院

第15章：乳房攝影影像市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章乳房攝影影像市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章乳房攝影影像市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國乳房攝影影像市場

第19章：中國乳房攝影影像市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Allengers Medical Systems Limited
  • Aurora Healthcare US Corp.
  • Canon Inc.
  • Carestream Health, Inc.
  • CMR Naviscan Corporation
  • Delphinus Medical Technologies, Inc.
  • Dilon Technologies, Inc.
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • iCAD, Inc.
  • Koninklijke Philips NV
  • Metaltronica SpA
  • Micrima Limited
  • Oncovision SA
  • Planmed Oy
  • QT Ultrasound LLC
  • Seno Medical Instruments, Inc.
  • Siemens Healthineers AG
  • Trivitron Healthcare Pvt. Ltd.
Product Code: MRR-43395F955F76

The Breast Imaging Market was valued at USD 5.83 billion in 2025 and is projected to grow to USD 6.31 billion in 2026, with a CAGR of 8.52%, reaching USD 10.35 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.83 billion
Estimated Year [2026] USD 6.31 billion
Forecast Year [2032] USD 10.35 billion
CAGR (%) 8.52%

An authoritative orientation to clinical imperatives and technological evolution redefining procurement, deployment, and care pathways in breast imaging

The breast imaging landscape is experiencing rapid technological maturation, converging clinical priorities, and heightened policy scrutiny that together redefine how providers, payers, and vendors approach detection and diagnosis. Recent advances in imaging hardware and software, including the refinement of multi-dimensional imaging techniques and the integration of advanced radiology workflows, are reshaping clinical pathways from screening through pre-surgical localization. At the same time, health systems are balancing capital constraints with imperatives to improve diagnostic accuracy, reduce recall rates, and expand access to underserved populations.

In practice, stakeholders are contending with a complex matrix of choices: whether to invest in modular systems that enable modality convergence, adopt mobile deployment models to increase reach, or prioritize software-driven improvements in image interpretation and interoperability. These decisions are influenced by reimbursement trajectories, workforce dynamics within radiology, and the accelerating adoption of artificial intelligence as a decision-support layer. Transitional forces such as migration from analog to digital imaging continue to influence procurement cycles, while regulatory and tariff developments add layers of uncertainty to capital planning.

This introduction sets the stage for a focused executive analysis that synthesizes technology trends, segmentation dynamics across product, modality, and end-user groups, and regional considerations that will inform strategic planning. The goal is to equip decision-makers with a clear, actionable understanding of the forces reshaping breast imaging so they can prioritize investments that deliver clinical impact and operational resilience.

Converging modality innovation, software integration, and distributed care models that are reshaping diagnostic pathways and operational priorities across breast imaging

The landscape of breast imaging is undergoing transformative shifts driven by advances in imaging modalities, software-enabled workflows, and changes in care delivery models that are collectively elevating diagnostic precision and operational flexibility. Three-dimensional and higher-dimensional imaging modalities are improving lesion characterization and surgical planning, while contrast-enhanced techniques and hybrid approaches are enhancing sensitivity in complex clinical scenarios. Concurrently, software innovation-spanning imaging software optimized for tomosynthesis and MRI, alongside radiology software that streamlines workflow and decision support-has become an essential complement to hardware investments.

Another pivotal shift is the movement toward distributed models of care, where mobile units and integrated systems enable screening and follow-up services outside of traditional hospital settings, expanding access and improving continuity of care. This operational transition is matched by a growing emphasis on interoperability and data governance as systems integrate imaging outputs with electronic health records and multidisciplinary care platforms. Meanwhile, workforce constraints and the proliferation of AI-assisted tools are prompting health systems to redesign radiology workflows to maintain quality while increasing throughput.

Together, these shifts underscore a redefinition of value in breast imaging: success is no longer measured solely by equipment capabilities but by the ability to deliver integrated, patient-centered diagnostic pathways that combine modality diversity, seamless software integration, and adaptive deployment strategies to meet evolving clinical needs.

How evolving tariff policies have reshaped supply chains, procurement strategies, and vendor relationships to prioritize resilience and total cost of ownership

Recent tariff policies enacted by the United States have introduced cumulative effects across supply chains that serve the breast imaging ecosystem, influencing procurement timelines, sourcing strategies, and vendor negotiations. Equipment manufacturers that rely on globalized manufacturing footprints have adjusted their supply chain architectures to mitigate increased input costs and customs duties, which has led to a reallocation of component sourcing, reengineering of product configurations, and, in some cases, shifts in production locations to preserve competitiveness.

Health systems and diagnostic centers have responded by re-evaluating procurement horizons, placing greater emphasis on total cost of ownership and lifecycle support rather than upfront capital expenditure alone. As a result, there is heightened interest in financing models, extended service agreements, and trade-in programs that spread financial impact and maintain access to advanced imaging capabilities. Furthermore, vendors are increasingly designing product portfolios with modularity in mind to enable phased upgrades that are less sensitive to tariff-induced price volatility.

In parallel, the tariff environment has accelerated dialogues around nearshoring and supplier diversification, prompting stakeholders to prioritize partners with resilient regional supply chains and robust after-sales support networks. This reorientation reflects a broader recognition that policy-driven cost pressures require adaptive procurement strategies, closer collaboration between clinical teams and supply chain leaders, and proactive contractual arrangements to safeguard continuity of care and capital planning.

Integrated segmentation analysis revealing how product, technology, equipment, modality, application, and end-user dynamics converge to shape strategic opportunities

Segmentation insights reveal that the market's dynamics are multifaceted, reflecting distinct drivers across products, technologies, equipment types, categories, imaging modalities, applications, and end users. From a product perspective, systems and software play complementary roles: systems encompass biopsy guidance, breast MRI, ultrasound, mammography, and tomosynthesis equipment, while software spans imaging platforms tailored to specific modalities and radiology solutions that enhance workflow efficiency and diagnostic consistency. This interplay illustrates how investment in advanced systems often necessitates parallel spending on software to unlock full clinical value.

Technology segmentation underscores a shift toward multidimensional imaging, with 3D and emerging 4D techniques increasingly integrated into clinical workflows to improve lesion conspicuity and motion characterization, while 2D imaging remains a core component of many screening programs. Equipment type considerations highlight choices among integrated systems designed for comprehensive workflows, mobile units that extend reach into community settings, and standalone devices that deliver targeted functionality with lower capital intensity. The category distinction between analog and digital imaging continues to shape upgrade cycles and interoperability requirements, as institutions prioritize digital conversion to enable image sharing and AI applications.

Imaging modality segmentation reveals a broad portfolio across breast tomosynthesis, contrast-enhanced mammography, digital mammography, MRI, molecular breast imaging, and ultrasound, each offering unique clinical advantages that inform application-specific deployment for biopsy, diagnostic mammography, pre-surgical localization, and screening. End-user segmentation spans ambulatory surgical centers, cancer research centers, diagnostic imaging centers, and hospitals, and each setting imposes distinct operational constraints, regulatory obligations, and adoption pathways. Synthesizing these segmentation layers clarifies where clinical demand meets operational feasibility and identifies high-impact opportunities for vendors and providers alike.

Regional deployment nuances across the Americas, Europe, Middle East & Africa, and Asia-Pacific that dictate tailored strategies for adoption and scale

Regional dynamics are influencing investment priorities, technology adoption, and operational strategies across three macro regions: Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, investment is often driven by a combination of institutional consolidation, emphasis on screening program optimization, and active private sector participation that accelerates adoption of tomosynthesis and advanced software platforms. Meanwhile, regulatory updates and reimbursement recalibrations encourage providers to modernize imaging fleets and incorporate tools that reduce recall rates and enhance diagnostic confidence.

In Europe, Middle East & Africa, the environment is diverse: Western European markets continue to prioritize digital transformation and integration of contrast-enhanced and MRI-based techniques, while markets in the Middle East and Africa often focus on expanding access through mobile screening initiatives and investment in scalable imaging systems. This heterogeneous landscape necessitates region-specific go-to-market strategies that account for regulatory complexity and variable infrastructure maturity. In Asia-Pacific, rapid urbanization and expanding healthcare investment are driving demand for both high-end modalities and accessible screening solutions. Local manufacturing and strong regional supplier ecosystems are also influencing procurement dynamics, enabling competitive product offerings that target both public and private sector needs.

Across these regions, strategic priorities converge around interoperability, workforce development, and pathway optimization, yet each region's unique combination of regulatory, economic, and infrastructure factors requires tailored approaches to deployment, partnership models, and clinical training programs.

How vendor differentiation, partnerships, and service excellence are driving competitive advantage and influencing adoption across diverse clinical settings

Competitive dynamics in the breast imaging arena are shaped by a mix of legacy equipment manufacturers, innovative software vendors, and emerging specialists focused on modality-specific solutions. Established players continue to leverage scale, service networks, and broad product portfolios across mammography, ultrasound, MRI, and tomosynthesis systems to maintain footprint in hospitals and large diagnostic centers. At the same time, software companies are differentiating through workflow automation, AI-enabled detection and triage capabilities, and cloud-based architectures that facilitate remote reading and multidisciplinary collaboration.

Newer entrants and niche specialists are targeting gaps in the market by developing modular devices optimized for mobile screening, cost-effective standalone units for decentralized care, and contrast-enhanced or molecular imaging solutions that address challenging diagnostic populations. Partnerships and alliances are increasingly common, with vendors collaborating to integrate imaging software with system hardware and to co-develop clinical validation studies that demonstrate real-world impact. Service and support remain critical competitive levers, as providers place a premium on rapid maintenance response, training programs, and flexible financing that reduce downtime and protect clinical throughput.

Collectively, these company-level dynamics emphasize the importance of interoperability, evidence generation, and post-sale engagement as differentiators in a market where clinical outcomes and operational continuity govern purchasing decisions.

Practical and prioritized strategic actions that align procurement, technology integration, and workforce readiness to accelerate clinical impact and operational resilience

Industry leaders seeking to capitalize on market momentum should prioritize a set of actionable strategies that align technology investments with clinical workflows and business objectives. First, invest in interoperable solutions that enable seamless integration between imaging systems and radiology software to support multidisciplinary care pathways and facilitate AI augmentation. By prioritizing open standards and scalable architectures, organizations can future-proof deployments and reduce friction when upgrading imaging modalities or workflow tools.

Second, adopt flexible procurement and financing structures that balance capital constraints with clinical imperatives. This includes exploring modular upgrade paths, managed service agreements, and asset lifecycle partnerships that reduce upfront burdens while preserving access to advanced imaging capabilities. Third, build resilient supply chain and vendor ecosystems by diversifying suppliers, prioritizing partners with strong regional support networks, and embedding contingency clauses that mitigate tariff and trade disruptions.

Finally, focus on people and process by investing in workforce development, clinical training, and change management initiatives that enable efficient adoption of new modalities and software. Operationalizing these recommendations will help leaders unlock higher diagnostic value, improve patient experience, and achieve sustainable competitive advantage in a rapidly evolving environment.

A transparent mixed-methods research framework combining primary clinician insight, regulatory review, and supply chain analysis to produce decision-ready intelligence

This analysis draws on a rigorous, mixed-methods research approach that triangulates qualitative and quantitative inputs to ensure robust, decision-ready insights. Primary research included structured interviews and in-depth discussions with clinical leaders, radiology directors, procurement specialists, and vendor executives to capture first-hand perspectives on adoption drivers, deployment challenges, and service expectations. Secondary research involved comprehensive review of peer-reviewed clinical studies, regulatory guidance, and publicly available technical specifications to validate performance attributes of key imaging modalities and software capabilities.

Additionally, supply chain and policy analyses were conducted to assess the operational implications of tariff changes and trade dynamics, focusing on manufacturing footprints, component dependencies, and aftermarket support models. Comparative vendor assessments evaluated product portfolios, integration approaches, and service propositions to identify differentiation factors and potential partnership opportunities. Throughout the process, findings were iteratively validated with industry stakeholders to ensure accuracy, practical relevance, and alignment with evolving clinical and regulatory trends.

This methodological framework ensures that the insights presented are grounded in real-world practice and reflect a balanced synthesis of clinical utility, operational feasibility, and strategic implications for decision-makers.

A decisive synthesis emphasizing integration of technology, people, and procurement adaptability to secure clinical excellence and operational resilience in breast imaging

In conclusion, the future of breast imaging will be determined by the interplay between modality innovation, software-driven workflow optimization, and strategic deployment models that extend access while preserving diagnostic quality. Institutions that align investments across systems and imaging software, adopt flexible procurement approaches, and invest in workforce readiness will be better positioned to translate technological advances into improved patient outcomes. The cumulative effects of policy shifts, including tariff dynamics, underscore the need for supply chain agility and vendor partnerships that can absorb cost variability without compromising service continuity.

Looking forward, stakeholders should remain attentive to the clinical evidence base around emerging modalities, prioritize interoperability to enable scalable AI adoption, and design procurement strategies that accommodate phased modernization. By doing so, providers and vendors can collaboratively advance screening efficiency, diagnostic accuracy, and patient-centered care pathways. The imperative is clear: integrate technology, people, and processes in a way that sustains both clinical excellence and operational resilience amidst a period of rapid evolution.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Breast Imaging Market, by Product

  • 8.1. Software
    • 8.1.1. Imaging Software
    • 8.1.2. Radiology Software
  • 8.2. Systems
    • 8.2.1. Biopsy Guidance Systems
    • 8.2.2. Breast MRI Systems
    • 8.2.3. Breast Ultrasound Systems
    • 8.2.4. Mammography Systems
    • 8.2.5. Tomosynthesis Systems

9. Breast Imaging Market, by Technology

  • 9.1. 2D Imaging
  • 9.2. 3D Imaging
  • 9.3. 4D Imaging

10. Breast Imaging Market, by Equipment Type

  • 10.1. Integrated Systems
  • 10.2. Mobile Units
  • 10.3. Standalone Devices

11. Breast Imaging Market, by Category

  • 11.1. Analog Imaging
  • 11.2. Digital Imaging

12. Breast Imaging Market, by Imaging Modality

  • 12.1. Breast Tomosynthesis
  • 12.2. Contrast Enhanced Mammography
  • 12.3. Digital Mammography
  • 12.4. Magnetic Resonance Imaging
  • 12.5. Molecular Breast Imaging
  • 12.6. Ultrasound Imaging

13. Breast Imaging Market, by Application

  • 13.1. Breast Biopsy
  • 13.2. Diagnostic Mammography
  • 13.3. Pre-Surgical Localization
  • 13.4. Screening Mammography

14. Breast Imaging Market, by End-User

  • 14.1. Ambulatory Surgical Centers
  • 14.2. Cancer Research Centers
  • 14.3. Diagnostic Imaging Centers
  • 14.4. Hospitals

15. Breast Imaging Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Breast Imaging Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Breast Imaging Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Breast Imaging Market

19. China Breast Imaging Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Allengers Medical Systems Limited
  • 20.6. Aurora Healthcare US Corp.
  • 20.7. Canon Inc.
  • 20.8. Carestream Health, Inc.
  • 20.9. CMR Naviscan Corporation
  • 20.10. Delphinus Medical Technologies, Inc.
  • 20.11. Dilon Technologies, Inc.
  • 20.12. FUJIFILM Holdings Corporation
  • 20.13. GE HealthCare Technologies Inc.
  • 20.14. Hologic, Inc.
  • 20.15. iCAD, Inc.
  • 20.16. Koninklijke Philips N.V.
  • 20.17. Metaltronica S.p.A.
  • 20.18. Micrima Limited
  • 20.19. Oncovision S.A.
  • 20.20. Planmed Oy
  • 20.21. QT Ultrasound LLC
  • 20.22. Seno Medical Instruments, Inc.
  • 20.23. Siemens Healthineers AG
  • 20.24. Trivitron Healthcare Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BREAST IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BREAST IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BREAST IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BREAST IMAGING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BREAST IMAGING MARKET SIZE, BY CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BREAST IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BREAST IMAGING MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BREAST IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BREAST IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL BREAST IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES BREAST IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA BREAST IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BREAST IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BREAST IMAGING MARKET SIZE, BY RADIOLOGY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BREAST IMAGING MARKET SIZE, BY RADIOLOGY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BREAST IMAGING MARKET SIZE, BY RADIOLOGY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BREAST IMAGING MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BREAST IMAGING MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BREAST IMAGING MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST MRI SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST MRI SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST MRI SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST ULTRASOUND SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST ULTRASOUND SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BREAST IMAGING MARKET SIZE, BY MAMMOGRAPHY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BREAST IMAGING MARKET SIZE, BY MAMMOGRAPHY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BREAST IMAGING MARKET SIZE, BY MAMMOGRAPHY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BREAST IMAGING MARKET SIZE, BY TOMOSYNTHESIS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BREAST IMAGING MARKET SIZE, BY TOMOSYNTHESIS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BREAST IMAGING MARKET SIZE, BY TOMOSYNTHESIS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BREAST IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BREAST IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BREAST IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BREAST IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BREAST IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BREAST IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BREAST IMAGING MARKET SIZE, BY 4D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BREAST IMAGING MARKET SIZE, BY 4D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BREAST IMAGING MARKET SIZE, BY 4D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BREAST IMAGING MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BREAST IMAGING MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BREAST IMAGING MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BREAST IMAGING MARKET SIZE, BY MOBILE UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BREAST IMAGING MARKET SIZE, BY MOBILE UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BREAST IMAGING MARKET SIZE, BY MOBILE UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BREAST IMAGING MARKET SIZE, BY STANDALONE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BREAST IMAGING MARKET SIZE, BY STANDALONE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BREAST IMAGING MARKET SIZE, BY STANDALONE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BREAST IMAGING MARKET SIZE, BY ANALOG IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BREAST IMAGING MARKET SIZE, BY ANALOG IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BREAST IMAGING MARKET SIZE, BY ANALOG IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST TOMOSYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST TOMOSYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST TOMOSYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BREAST IMAGING MARKET SIZE, BY CONTRAST ENHANCED MAMMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BREAST IMAGING MARKET SIZE, BY CONTRAST ENHANCED MAMMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BREAST IMAGING MARKET SIZE, BY CONTRAST ENHANCED MAMMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BREAST IMAGING MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BREAST IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BREAST IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BREAST IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BREAST IMAGING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BREAST IMAGING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BREAST IMAGING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BREAST IMAGING MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BREAST IMAGING MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BREAST IMAGING MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BREAST IMAGING MARKET SIZE, BY BREAST BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC MAMMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC MAMMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC MAMMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BREAST IMAGING MARKET SIZE, BY PRE-SURGICAL LOCALIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BREAST IMAGING MARKET SIZE, BY PRE-SURGICAL LOCALIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BREAST IMAGING MARKET SIZE, BY PRE-SURGICAL LOCALIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BREAST IMAGING MARKET SIZE, BY SCREENING MAMMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BREAST IMAGING MARKET SIZE, BY SCREENING MAMMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BREAST IMAGING MARKET SIZE, BY SCREENING MAMMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BREAST IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BREAST IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BREAST IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BREAST IMAGING MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BREAST IMAGING MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BREAST IMAGING MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BREAST IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BREAST IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BREAST IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BREAST IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BREAST IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS BREAST IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL BREAST IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 196. GCC BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. GCC BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 198. GCC BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 200. GCC BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. GCC BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 203. GCC BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. GCC BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 226. G7 BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. G7 BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 228. G7 BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 230. G7 BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. G7 BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 233. G7 BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 234. G7 BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. G7 BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 236. NATO BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. NATO BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 238. NATO BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 239. NATO BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 240. NATO BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. NATO BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. NATO BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 243. NATO BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 244. NATO BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. NATO BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL BREAST IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES BREAST IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA BREAST IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA BREAST IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA BREAST IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA BREAST IMAGING MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA BREAST IMAGING MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA BREAST IMAGING MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA BREAST IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA BREAST IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA BREAST IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)